louisiana semaglutide ileus lawsuit kentucky glp-1 gastric intestinal obstruction attorney semaglutide diarrhea law firm in kentucky semaglutide kentucky semaglutide ileus attorney glp-1

Just know this has not yet been evaluated in clinical trials

New York City officials said in 2024 they, too, were dropping coverage for weight-loss drugs after reportedly saying they had been paying for them in error . More than 40,000 customers of Massachusetts two biggest insurers, Blue Cross and Point32Health, have lost coverage of GLP-1s for obesity this year, according to the data the companies provided to the Globe

This longer gap increases the risk of appetite return and weight regain, so most providers avoid it unless specifically indicated for side effect management

Improved microbiota composition may further enhance semaglutides efficacy and tolerability by lowering gut-derived inflammation, thus potentially optimising GLP-1 analogue action (Fig